leadf
logo-loader
viewAdmiralty Resources Ltd

Admiralty Resources raising funds to progress Chile iron ore exploration and development

au_chile__350_5362dc9d317a1.jpg

Admiralty Resources (ASX: ADY) is raising up to $3.9 million to advance exploration at the Harper South and Pampa Tololo iron ore districts in Chile and advance the Soberana iron ore project.
   
The funds will be raised through a non-renounceable 1 for 3 rights offer of 243,348,327 shares priced at $0.016 each.

This is underwritten by Jin Xin International for the amount of the shortfall equal to the lesser of the either number of shares in the shortfall or the number of shares that when combined with the shares already held by the underwriter is closest to 20% of the total shares on issue.

Proceeds will be used to accelerate its existing exploration program at the Harper South and Pampa Tololo districts in Chile, advance the Soberana project towards early production and to provide the Company with additional working capital.

It will also provide Admiralty with additional working capital to enable it to support its activities and the retirement of some debt relating to the convertible loan facility agreements in place.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Admiralty Resources Ltd

Price: 0.013 AUD

ASX:ADY
Market: ASX
Market Cap: $15.07 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Amryt Pharma presents at the Proactive One2One virtual conference

Amryt Pharma's LON:AMYT) Rory Nealon presents at the Proactive One2One virtual conference. Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases. The company...

8 hours, 57 minutes ago

2 min read